Recommended Needle Size for IM Deltoid Injection
For adults, a 22-25 gauge, 1-1½ inch needle is recommended for deltoid intramuscular injections. 1, 2
Needle Size Recommendations by Age Group
- Adults (>18 years): 22-25 gauge, 1-1½ inch needle for deltoid IM injections 1, 2
- Children (12 months-18 years): 22-25 gauge, 7/8-1¼ inch needle when using the deltoid muscle (if muscle mass is adequate) 1, 2
- Infants (<12 months): 22-25 gauge, 7/8-1 inch needle primarily for anterolateral thigh (deltoid can be used if necessary) 1
Factors Affecting Needle Length Selection
- Gender differences: Women have significantly thicker deltoid fat pads (11.7 mm vs 8.3 mm in men), requiring careful consideration of needle length 3
- Body weight considerations:
Injection Technique
- Insert the needle at a 90-degree angle to ensure proper muscle penetration 2
- The needle should be long enough to reach the muscle mass but not so long as to involve underlying nerves, blood vessels, or bone 1
- For all intramuscular injections, ensure the needle can penetrate through subcutaneous tissue and reach the muscle to prevent vaccine from seeping into subcutaneous tissue 1
Optimal Injection Site
- The recommended site is approximately 4 cm distal to the posterolateral corner of the acromion 4, 5
- This site maximizes successful intramuscular administration while minimizing risk of overpenetration and avoiding the axillary nerve 4
- Never inject in the upper half of the deltoid muscle to avoid injury to underlying neurovascular structures 5
Common Pitfalls to Avoid
- Using too short a needle: In obese patients, standard 25 mm needles may be insufficient to reach muscle tissue, particularly in women with BMI >35 2, 6, 7
- Using the same needle length for all patients: Consider patient's body habitus, sex, and BMI when selecting needle length 2, 3
- Improper injection site: Injecting too high in the deltoid increases risk of injury to the axillary nerve and posterior circumflex humeral artery 4, 5
- Buttock injections: Avoid using the buttock for vaccine administration due to risk of sciatic nerve injury and decreased immunogenicity 1, 2